Regulation of Hippo Signaling by Actin Remodeling

Overview

Journal BMB Rep

Specialties Biochemistry
Molecular Biology

Date 2018 Jan 23

PMID 29353600

Citations 71

Authors

Jimyung Seo

Joon Kim

Affiliations

Soon will be listed here.

Abstract

The Hippo signaling pathway controls nuclear accumulation and stability of the transcriptional coregulator YAP and its paralog TAZ. The activity of Hippo-YAP signaling is influenced not only by biochemical signals, but also by cell shape and mechanical tension transmitted through cell-cell junctions and cell-matrix adhesions. Data accumulated thus far indicates that the actin cytoskeleton is a key mediator of the regulation of Hippo-YAP signaling by means of a variety of biochemical and mechanical cues. In this review, we have outlined the role of actin dynamics and actin-associated proteins in the regulation of Hippo-YAP signaling. In addition, we discuss actinmediated regulation of YAP/TAZ activity independent of the core Hippo kinases MST and LATS. Although our understanding of the link between Hippo-YAP signaling and the actin cytoskeleton is progressing rapidly, many open questions remain. [BMB Reports 2018; 51(3): 151-156].

Citing Articles

Regulation of trophectoderm morphogenesis by small GTPase RHOA through HIPPO signaling-dependent and -independent mechanisms in mouse preimplantation development.

Marikawa Y, Alarcon V Differentiation. 2025; 141:100835.

PMID: 39874642 PMC: 11790356. DOI: 10.1016/j.diff.2025.100835.

Hippo Signaling Pathway Involvement in Osteopotential Regulation of Murine Bone Marrow Cells Under Simulated Microgravity.

Tyrina E, Yakubets D, Markina E, Buravkova L Cells. 2024; 13(22).

PMID: 39594669 PMC: 11592674. DOI: 10.3390/cells13221921.

ASAP1 and ARF1 Regulate Myogenic Differentiation in Rhabdomyosarcoma by Modulating TAZ Activity.

Hebron K, Perkins O, Kim A, Jian X, Girald-Berlingeri S, Lei H Mol Cancer Res. 2024; 23(2):95-106.

PMID: 39495123 PMC: 11799837. DOI: 10.1158/1541-7786.MCR-24-0490.

Pannexin 1 crosstalk with the Hippo pathway in malignant melanoma.

Sayedyahossein S, Huang K, Zhang C, Karimi M, Bahmani M, ODonnell B bioRxiv. 2024; .

PMID: 39372769 PMC: 11451602. DOI: 10.1101/2024.09.03.611059.

Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment.

Wang H, Yung M, Xuan Y, Chen F, Chan W, Siu M Exp Hematol Oncol. 2024; 13(1):90.

PMID: 39198883 PMC: 11360340. DOI: 10.1186/s40164-024-00558-8.

References

Trofatter J, MacCollin M, Rutter J, Murrell J, Duyao M, Parry D . A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993; 75(4):826. DOI: 10.1016/0092-8674(93)90501-g. View

Feng X, Degese M, Iglesias-Bartolome R, Vaque J, Molinolo A, Rodrigues M . Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell. 2014; 25(6):831-45. PMC: 4074519. DOI: 10.1016/j.ccr.2014.04.016. View

Yu F, Zhang Y, Park H, Jewell J, Chen Q, Deng Y . Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 2013; 27(11):1223-32. PMC: 3690396. DOI: 10.1101/gad.219402.113. View

Matsui Y, Lai Z . Mutual regulation between Hippo signaling and actin cytoskeleton. Protein Cell. 2013; 4(12):904-10. PMC: 4875399. DOI: 10.1007/s13238-013-3084-z. View

Fischer M, Rikeit P, Knaus P, Coirault C . YAP-Mediated Mechanotransduction in Skeletal Muscle. Front Physiol. 2016; 7:41. PMC: 4754448. DOI: 10.3389/fphys.2016.00041. View

Murrell M, Oakes P, Lenz M, Gardel M . Forcing cells into shape: the mechanics of actomyosin contractility. Nat Rev Mol Cell Biol. 2015; 16(8):486-98. PMC: 7443980. DOI: 10.1038/nrm4012. View

Schroeder M, Halder G . Regulation of the Hippo pathway by cell architecture and mechanical signals. Semin Cell Dev Biol. 2012; 23(7):803-11. DOI: 10.1016/j.semcdb.2012.06.001. View

Benham-Pyle B, Pruitt B, Nelson W . Cell adhesion. Mechanical strain induces E-cadherin-dependent Yap1 and β-catenin activation to drive cell cycle entry. Science. 2015; 348(6238):1024-7. PMC: 4572847. DOI: 10.1126/science.aaa4559. View

Sansores-Garcia L, Bossuyt W, Wada K, Yonemura S, Tao C, Sasaki H . Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 2011; 30(12):2325-35. PMC: 3116287. DOI: 10.1038/emboj.2011.157. View

10.

Clark K, Langeslag M, Figdor C, van Leeuwen F . Myosin II and mechanotransduction: a balancing act. Trends Cell Biol. 2007; 17(4):178-86. DOI: 10.1016/j.tcb.2007.02.002. View

11.

Meng Z, Moroishi T, Guan K . Mechanisms of Hippo pathway regulation. Genes Dev. 2016; 30(1):1-17. PMC: 4701972. DOI: 10.1101/gad.274027.115. View

12.

McClatchey A, Giovannini M . Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin. Genes Dev. 2005; 19(19):2265-77. DOI: 10.1101/gad.1335605. View

13.

Furukawa K, Yamashita K, Sakurai N, Ohno S . The Epithelial Circumferential Actin Belt Regulates YAP/TAZ through Nucleocytoplasmic Shuttling of Merlin. Cell Rep. 2017; 20(6):1435-1447. DOI: 10.1016/j.celrep.2017.07.032. View

14.

Lucas E, Khanal I, Gaspar P, Fletcher G, Polesello C, Tapon N . The Hippo pathway polarizes the actin cytoskeleton during collective migration of Drosophila border cells. J Cell Biol. 2013; 201(6):875-85. PMC: 3678158. DOI: 10.1083/jcb.201210073. View

15.

Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N . A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell. 2013; 154(5):1047-1059. DOI: 10.1016/j.cell.2013.07.042. View

16.

Piccolo S, Dupont S, Cordenonsi M . The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev. 2014; 94(4):1287-312. DOI: 10.1152/physrev.00005.2014. View

17.

Wang W, Huang J, Chen J . Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem. 2010; 286(6):4364-70. PMC: 3039387. DOI: 10.1074/jbc.C110.205401. View

18.

Zhao B, Li L, Lu Q, Wang L, Liu C, Lei Q . Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011; 25(1):51-63. PMC: 3012936. DOI: 10.1101/gad.2000111. View

19.

Butcher D, Alliston T, Weaver V . A tense situation: forcing tumour progression. Nat Rev Cancer. 2009; 9(2):108-22. PMC: 2649117. DOI: 10.1038/nrc2544. View

20.

Strambio-De-Castillia C, Niepel M, Rout M . The nuclear pore complex: bridging nuclear transport and gene regulation. Nat Rev Mol Cell Biol. 2010; 11(7):490-501. DOI: 10.1038/nrm2928. View